A carregar...

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis

SUMMARY: ‘Rebound’ or ‘withdrawal’ symptoms are frequently observed after a sudden discontinuation of clozapine. We describe a patient with treatment-resistant schizoaffective disorder who developed agranulocytosis on clozapine but was successfully switched to treatment with olanzapine with no deter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BJPsych Open
Main Authors: Green, Alastair, Stephenson, Thomas, Whiskey, Eromona, Shergill, Sukhi S.
Formato: Artigo
Idioma:Inglês
Publicado em: Cambridge University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537554/
https://ncbi.nlm.nih.gov/pubmed/31530315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjo.2019.31
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!